Get started
Author

Abner Herbert Lim

Observed names: A. Lim, ABNER HERBERT LIM, Abner Herbert Lim, Abner H Lim, Abner H. Lim, Abner Lim, Abner M. S. Lim, Lim, Abner, Lim, Abner Herbert
Observed institutions: Agency for Science, Technology and Research, SingHealth, National University of Singapore, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, National Cancer Centre Singapore, Genome Institute of Singapore
ORCID: 0000-0003-0598-1568
Observed ORCID: 0000-0003-0598-1568
OpenAlex ID: A5001303390
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
2022 · Ryan Shea Ying Cong Tan, Whee Sze Ong, et al. · BMC Medicine · 128
PDF
Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing
2021 · Cedric Chuan Young Ng, Nur Diyana Md Nasir, et al. · Modern Pathology · 34
PDF
NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
2022 · Lui Shiong Lee, Adelene Y. L. Sim, et al. · Prostate Cancer and Prostatic Diseases · 28
PDF
The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy
2022 · Jing Yi Lee, Bavani Kannan, et al. · International Journal of Molecular Sciences · 27
PDF
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma
2023 · Jui Wan Loh, Jing Yi Lee, et al. · Communications Biology · 26
PDF
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies
2023 · Jing Han Hong, Chern Han Yong, et al. · Gut · 24
Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis
2022 · Josephine Hendrikson, Ying Liu, et al. · Cell Reports Medicine · 16
PDF
Bizarre giant cells in human angiosarcoma exhibit chemoresistance and contribute to poor survival outcomes
2020 · Grace Fangmin Tan, Shane Goh, et al. · Cancer Science · 16
PDF
Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor
2022 · Dave Yong Xiang Ng, Zhimei Li, et al. · npj Breast Cancer · 12
PDF
Genome assembly and chemogenomic profiling of National Flower of Singapore Papilionanthe Miss Joaquim ‘Agnes’ reveals metabolic pathways regulating floral traits
2022 · Abner Herbert Lim, Zhen Jie Low, et al. · Communications Biology · 10
PDF
Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
2022 · Abner Herbert Lim, Jason Yongsheng Chan, et al. · Cancers · 9
PDF
Genomic Landscapes of Acral Melanomas in East Asia
2021 · JOHN WEN-CHENG CHANG, JIA-JUAN HSIEH, et al. · Cancer Genomics & Proteomics · 9
PDF
Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma
2020 · Jason Y. Chan, Abner H. Lim, et al. · Liver Cancer International · 8
PDF
PSiTE: a Phylogeny guided Simulator for Tumor Evolution
2019 · Hechuan Yang, Bingxin Lu, et al. · Bioinformatics · 8
A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples
2022 · Cedric Chuan-Young Ng, Sandy Lim, et al. · Frontiers in Molecular Biosciences · 7
Multi-omic profiling and real time ex vivo modelling of imatinib-resistant dermatofibrosarcoma protuberans with fibrosarcomatous transformation
2023 · Jason Yongsheng Chan, Elizabeth Chun Yong Lee, et al. · Human Cell · 6
Biodiversity Medicine: New Horizon and New Opportunity for Cancer
2024 · Jing Han Hong, Abner Herbert Lim, et al. · Cancer Discovery · 5
PDF
Aristolochic acid‐related renal cell carcinoma exhibits a distinct tumor‐immune microenvironment favoring response to immune checkpoint blockade
2024 · Po‐Hung Lin, Jason Yongsheng Chan, et al. · The Journal of Pathology · 3
PDF
Whole genome sequencing of HER2-positive metastatic extramammary Paget’s disease: a case report
2024 · Boon Yee Lim, Zexi Guo, et al. · Orphanet Journal of Rare Diseases · 3
Integrative Metabolomics, Genomics, and Transcriptomics Analysis Unravels Anti-Cancer Potential of Secondary Metabolites in Dillenia Suffruticosa
2023 · Norhayati Ahmad, Sabri Mohd. Ali, et al. · Research Square · 3
PDF
Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations
2023 · Jui Wan Loh, Abner Herbert Lim, et al. · Therapeutic Advances in Medical Oncology · 3
Establishment and characterization of a patient-derived solitary fibrous tumor/hemangiopericytoma cell line model
2023 · Jing Yi Lee, Peiyong Guan, et al. · Human Cell · 2
PDF
Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia ( PASH )‐like change: clinicopathological and molecular characteristics
2023 · Julie M Jorns, Ayesha Farooq, et al. · Histopathology · 2
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers
2026 · Jing Han Hong, Chern Han Yong, et al. · Science Translational Medicine · 1
Anti-cancer activity of propolis extracts from stingless bees of Brunei Darussalam
2025 · Boon Yee Lim, Abner Herbert Lim, et al. · Scientific Reports · 1
PDF
Works count: 48
Citation count: 395
H-index: 10
I10-index: 10
Year
Topic
Type